MAPT and amyloidosis: Holubova et al. observed the neuroprotective properties of a lipidized PrRP analog in a mice model of amyloidosis throughout a significant reduction in β-amyloid plaque burden, in microglia-mediated inflammation, in tau phosphorylation, and an increase in adult neurogenesis [53].